MedTrace Logo

Modafinil Treatment for Cocaine-Dependent Individuals

NCT00129285 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2018-05-08

Study results available
· View outcomes & findings →

Summary

Despite years of active research, there are still no approved medications for the treatment of cocaine dependence. The purpose of this study is to determine the effectiveness of modafinil in treating cocaine-dependent individuals.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Low Dose Modafinil

modafinil 200 mg/day

DRUG

High Dose Modafinil

modafinil 400 mg/day

DRUG

Placebo

placebo 400 mg/day

Sponsors & Collaborators

Principal Investigators

  • Charles Dackis · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2008-01-31
Completion
2008-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00129285 on ClinicalTrials.gov